RNF43 p.G659fs 通过 PI3K/AKT/mTOR 信号通路和 HLA-E 上调导致 MSI-high 结直肠癌中 NK 细胞功能障碍
RNF43 p.G659fs leads to natural killer cell dysfunction in MSI-high colorectal cancer through PI3K/AKT/mTOR signaling and HLA-E up-regulation.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Master regulator: p53's pivotal role in steering NK-cell tumor patrol.
Master regulator: p53's pivotal role in steering NK-cell tumor patrol.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
p53蛋白由TP53基因编码,是一种肿瘤抑制因子,通过调控多种下游信号,在调节肿瘤细胞凋亡、细胞周期调控和血管生成中发挥关键作用。自然杀伤(NK)细胞介导的免疫监视是抵御癌症和其他疾病的重要自我防御机制,NK细胞活性受多种机制调控。其中,p53通过维持NK细胞的稳态和功能,在免疫调节中发挥重要作用。它增强NK细胞活化配体的转录活性,并下调抑制性配体,从而增强NK细胞活化和杀瘤效能。
此外,p53通过促进不同肿瘤细胞中的凋亡、自噬和铁死亡,影响NK细胞毒性。p53通过多种途径参与调控NK细胞活性和效应功能。p53在肿瘤微环境(TME)中也发挥关键作用,调控NK细胞的活性。NK细胞是TME的重要组成部分,能够直接杀伤肿瘤细胞。p53在多种癌症中发生突变,最常见的改变是错义突变。这些突变通常与癌症患者较差的生存率相关。本综述详细阐述了p53在NK细胞肿瘤免疫监视中的作用,总结了p53如何增强NK细胞识别和肿瘤破坏。
我们还探讨了p53在肿瘤免疫治疗中的潜在应用,讨论了调控p53以增强NK细胞功能、提高肿瘤免疫治疗疗效的策略,以及相关挑战。理解TME中p53与NK细胞之间的相互作用,对于推进基于NK细胞的免疫治疗和开发p53相关新型治疗药物至关重要。
The p53 protein, encoded by TP53, is a tumor suppressor that plays a critical role in regulating apoptosis, cell cycle regulation, and angiogenesis in tumor cells via controlling various downstream signals. Natural killer (NK) cell-mediated immune surveillance is a vital self-defense mechanism against cancer and other diseases, with NK cell activity regulated by various mechanisms.
Among these, p53 plays a significant role in immune regulation by maintaining the homeostasis and functionality of NK cells. It enhances the transcriptional activity of NK cell-activating ligands and downregulates inhibitory ligands to boost NK cell activation and tumor-killing efficacy.
Additionally, p53 influences NK cell cytotoxicity by promoting apoptosis, autophagy, and ferroptosis in different tumor cells. p53 is involved in the regulation of NK cell activity and effector functions through multiple pathways. p53 also plays a pivotal role in the tumor microenvironment (TME), regulating the activity of NK cells.
NK cells are critical components of the TME and are capable of directly killing tumor cells. And p53 mutates in numerous cancers, with the most common alteration being a missense mutation. These mutations are commonly associated with poor survival rates in patients with cancer. This review details p53's role in NK cell tumor immunosurveillance, summarizing how p53 enhances NK cell recognition and tumor destruction.
We also explore the potential applications of p53 in tumor immunotherapy, discussing strategies for modulating p53 to enhance NK cell function and improve the efficacy of tumor immunotherapy, along with the associated challenges. Understanding the interaction between p53 and NK cells within the TME is crucial for advancing NK cell-based immunotherapy and developing p53-related novel therapeutics.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。